PlaqueTec Ltd. Company Profile

08:06 EDT 23rd July 2018 | BioPortfolio

News Articles [3 Associated News Articles listed on BioPortfolio]

PlaqueTec Sponsors and Presents Data at Vulnerable Patient Meeting

Distinguished faculty of about 75-100 global cardiology leaders meet by invitation only to advance the study and practice of atherosclerosis PlaqueTec announced today that it ...

Personalizing prevention

PlaqueTec plans to bring precision medicine to cardiovascular prevention with a catheter technology that enables biomarker discovery.

PlaqueTec Data Presented at EAS Show Lack of Correlation between Localised Coronary Artery Inflammatory Biomarker Expression and Systemic Elevation of Biomarkers including hsCRP

Analysis of intracoronary blood samples obtained via PlaqueTec’s Liquid Biopsy System suggests coronary inflammation may be independent of systemic inflammatory biomarkers ...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Study of the Vascular Response to Percutaneous Coronary Intervention in Patients With Non-ST-elevation Acute Coronary Syndromes Using Intravascular Blood Sampling

This interventional study is using the PlaqueTec LBS will enrol participants already undergoing coronary angiography as a component of their standard care for NSTE-ACS. The study will invo...

More Information about "PlaqueTec Ltd." on BioPortfolio

We have published hundreds of PlaqueTec Ltd. news stories on BioPortfolio along with dozens of PlaqueTec Ltd. Clinical Trials and PubMed Articles about PlaqueTec Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PlaqueTec Ltd. Companies in our database. You can also find out about relevant PlaqueTec Ltd. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record